" class="no-js "lang="en-US"> HealthBeats - Medtech Alert
Tuesday, October 14, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
HealthBeats | Pharmtech Focus

HealthBeats

About HealthBeats

HealthBeats™ is a global Remote Vitals Monitoring platform designed to bring healthcare home. We provide users with medical devices to be self-administered regularly at home and have their results transmitted real-time to their health providers for proactive care management for better health outcomes. HealthBeats™ uses multiple devices across multiple brands to meet the needs of its users and is the appointed global distributor for multiple brands of medical devices

Related Story

Fundraising

 HealthBeats Raises US$3m Seed Funding Led By Heritas Capital And SEEDS Capital To Expand Remote Vitals Monitoring In Australia And Singapore | Pharmtech Focus

HealthBeats Raises US$3m Seed Funding Led By Heritas Capital And SEEDS Capital To Expand Remote Vitals Monitoring In Australia And Singapore

April 29 2022

HealthBeatsTM, a Singapore-based healthtech start-up with end-to-end remote vitals monitoring solution, today announced the close of […]